… Dr Chris Finch is a speaker for GSK (Advair) and consultant for Sunovion Pharmaceuticals
(Brovana). No financial support was received for this manuscript. The authors report no …

Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of
well-documented clinically significant interactions include interactions with warfarin, oral …

Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and
the P-glycoprotein transport system. Among numerous well documented, clinically …

… Borcherding et al, 3 Strayhorn et al, 4 and Finch et al. Additional study needed to clearly
establish clinical significance. Carefully adjust doses when rifampin use is discontinued. …

Background Chronic obstructive pulmonary disease (COPD) is a chronic and progressive
disease that affects an estimated 10% of the world’s population over the age of 40 years. …

To determine the safety and tolerability of IV and oral levetiracetam monotherapy for seizures
in brain tumor patients following resection. Brain tumor patients undergoing neurosurgery …

BACKGROUND: Due to high rates of resistance and a limited number of efficacious antimicrobials
for vancomycin‐resistant Enterococcus (VRE), appropriate antibiotic selection is vital …

This study was conducted to identify current practice in provision of enteral nutrition (EN)
and to determine effects of early enteral nutrition (EEN) on length of stay in the medical …

The ASHP Foundation Pharmacy Forecast has been a valuable source of insight and
guidance about our profession as it is influenced by or influences external factors in our …

Background: Pharmacists ability to directly impact patient satisfaction through increases in
the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys …